AMG National Trust Bank Sells 1,454 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

AMG National Trust Bank decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.3% during the 2nd quarter, Holdings Channel reports. The firm owned 12,682 shares of the company’s stock after selling 1,454 shares during the period. AMG National Trust Bank’s holdings in GE HealthCare Technologies were worth $988,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in GEHC. US Bancorp DE raised its position in GE HealthCare Technologies by 83.4% during the 4th quarter. US Bancorp DE now owns 146,524 shares of the company’s stock valued at $11,329,000 after purchasing an additional 66,638 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its holdings in shares of GE HealthCare Technologies by 23.7% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 97,127 shares of the company’s stock valued at $7,510,000 after acquiring an additional 18,634 shares in the last quarter. Global Assets Advisory LLC purchased a new stake in GE HealthCare Technologies in the first quarter worth $4,273,000. Vanguard Group Inc. lifted its stake in GE HealthCare Technologies by 9.2% in the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after acquiring an additional 4,107,746 shares during the period. Finally, Hsbc Holdings PLC boosted its holdings in GE HealthCare Technologies by 21.1% in the fourth quarter. Hsbc Holdings PLC now owns 470,993 shares of the company’s stock valued at $36,408,000 after acquiring an additional 81,916 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several research analyst reports. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 target price for the company. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Bank of America reduced their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Mizuho lowered their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Finally, The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target on the stock. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $95.00.

GE HealthCare Technologies Stock Up 0.5 %

NASDAQ:GEHC traded up $0.41 during trading hours on Friday, reaching $84.78. 1,511,760 shares of the company traded hands, compared to its average volume of 3,015,838. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The stock has a market capitalization of $38.70 billion, a P/E ratio of 24.79, a P/E/G ratio of 3.00 and a beta of 1.17. The business’s 50-day moving average price is $80.77 and its two-hundred day moving average price is $83.41. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the previous year, the firm earned $0.92 EPS. GE HealthCare Technologies’s quarterly revenue was up .5% compared to the same quarter last year. Analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s payout ratio is 3.51%.

Insider Activity at GE HealthCare Technologies

In other news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The disclosure for this sale can be found here. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.